时间
发表于 2025-3-21 19:11:52
书目名称Biomarkers for Immunotherapy of Cancer影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0187799<br><br> <br><br>书目名称Biomarkers for Immunotherapy of Cancer影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0187799<br><br> <br><br>书目名称Biomarkers for Immunotherapy of Cancer网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0187799<br><br> <br><br>书目名称Biomarkers for Immunotherapy of Cancer网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0187799<br><br> <br><br>书目名称Biomarkers for Immunotherapy of Cancer被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0187799<br><br> <br><br>书目名称Biomarkers for Immunotherapy of Cancer被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0187799<br><br> <br><br>书目名称Biomarkers for Immunotherapy of Cancer年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0187799<br><br> <br><br>书目名称Biomarkers for Immunotherapy of Cancer年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0187799<br><br> <br><br>书目名称Biomarkers for Immunotherapy of Cancer读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0187799<br><br> <br><br>书目名称Biomarkers for Immunotherapy of Cancer读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0187799<br><br> <br><br>
古董
发表于 2025-3-21 21:09:41
http://reply.papertrans.cn/19/1878/187799/187799_2.png
开始从未
发表于 2025-3-22 01:48:05
The CRISPR System and Cancer Immunotherapy Biomarkersedly speed up the development of new treatment options for cancer patients. The CRISPR system and its applications in biomedical research will be discussed with an emphasis on cancer immunotherapy and biomarker development.
勉强
发表于 2025-3-22 06:40:37
Konflikte in modernen Gesellschaften (I),identifying germline biomarkers that disrupt miRNA circuitry, and then the selection, application, and validation of these biomarkers and their potential to predict important outcomes to checkpoint therapy.
豪华
发表于 2025-3-22 12:42:23
http://reply.papertrans.cn/19/1878/187799/187799_5.png
不透气
发表于 2025-3-22 15:27:52
1064-3745 ation advice from the experts.This book provides the immune oncology (IO) community with a deeper understanding of the scope of the biomarker methods to potentially improve the outcome from immunotherapy. The editors secured the input from experts in the field dedicated to translating scientific res
SPER
发表于 2025-3-22 17:07:59
http://reply.papertrans.cn/19/1878/187799/187799_7.png
Abominate
发表于 2025-3-22 23:47:12
http://reply.papertrans.cn/19/1878/187799/187799_8.png
烧瓶
发表于 2025-3-23 02:27:02
http://reply.papertrans.cn/19/1878/187799/187799_9.png
元音
发表于 2025-3-23 08:20:22
https://doi.org/10.1007/978-3-658-04584-5 adding sophistication and accuracy to the investigations. Here, we summarize the history of functional genomic profiling as a discovery and validation tool for immune oncology (IO) and new insights that could be derived by single novel technologies.